Read + Share
Amedeo Smart
Independent Medical Education
De Giorgi V, Trane L, Savarese I, Silvestri F, et al. Lasting response after discontinuation of Cemiplimab in a patient with locally advanced basal cell carcinoma. Clin Exp Dermatol 2021 Jun 22. doi: 10.1111/ced.14804.PMID: 34157152
Email
LinkedIn
Facebook
Twitter
Privacy Policy